Westover Capital Advisors LLC Increases Stake in Cardinal Health, Inc. $CAH

Westover Capital Advisors LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 75.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,262 shares of the company’s stock after acquiring an additional 1,837 shares during the period. Westover Capital Advisors LLC’s holdings in Cardinal Health were worth $716,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the business. Counterpoint Mutual Funds LLC purchased a new stake in Cardinal Health during the 2nd quarter valued at approximately $1,911,000. Atlantic Union Bankshares Corp purchased a new position in shares of Cardinal Health in the second quarter worth $79,000. KLP Kapitalforvaltning AS boosted its position in shares of Cardinal Health by 4.0% during the second quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after acquiring an additional 4,400 shares during the last quarter. Czech National Bank grew its stake in Cardinal Health by 5.1% during the second quarter. Czech National Bank now owns 58,341 shares of the company’s stock valued at $9,801,000 after acquiring an additional 2,857 shares in the last quarter. Finally, Acadian Asset Management LLC grew its stake in Cardinal Health by 92.5% during the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after acquiring an additional 807,063 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the transaction, the chief executive officer directly owned 200,000 shares of the company’s stock, valued at $30,008,000. The trade was a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.12% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Citigroup increased their price target on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research note on Friday, October 31st. Mizuho lifted their price objective on Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research note on Monday, November 3rd. Finally, UBS Group upped their price objective on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $206.46.

Cardinal Health Trading Up 0.4%

CAH opened at $206.25 on Tuesday. The stock has a 50-day moving average of $166.70 and a 200 day moving average of $159.64. Cardinal Health, Inc. has a 12 month low of $114.60 and a 12 month high of $208.32. The firm has a market cap of $49.00 billion, a P/E ratio of 31.98, a P/E/G ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.